CAM 2028Alternative Names: Benzydamine CR; CAM2028; Episil; episil; episil® oral liquid; SP-03 - Camurus
Latest Information Update: 09 Mar 2017
At a glance
- Originator Camurus
- Developer Camurus; Solasia Pharma; Takeda Pharmaceuticals International GmbH
- Class Analgesics
- Mechanism of Action Cyclooxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Stomatitis